These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24597641)

  • 1. New surprises of suppressor of cytokine signalling in liver fibrosis.
    Cheng C; Huang C; Ma TT; Xu T; Wang YR; Zhang L; Jun L
    Expert Opin Ther Targets; 2014 Apr; 18(4):415-26. PubMed ID: 24597641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of methyl-CpG binding protein 2 in liver fibrosis.
    Bian EB; Huang C; Wang H; Chen XX; Tao H; Zhang L; Lv XW; Li J
    Toxicology; 2013 Jul; 309():9-14. PubMed ID: 23619607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery.
    Bian EB; Zhao B; Huang C; Wang H; Meng XM; Wu BM; Ma TT; Zhang L; Lv XW; Li J
    Cell Signal; 2013 Sep; 25(9):1837-44. PubMed ID: 23707524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of microRNAs in liver fibrosis.
    He Y; Huang C; Zhang SP; Sun X; Long XR; Li J
    Cell Signal; 2012 Dec; 24(12):2268-72. PubMed ID: 22884954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins.
    Dalpke A; Heeg K; Bartz H; Baetz A
    Immunobiology; 2008; 213(3-4):225-35. PubMed ID: 18406369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of cytokine signaling 3 inhibits head kidney macrophage activation and cytokine expression in Scophthalmus maximus.
    Zhang M; Xiao ZZ; Sun L
    Dev Comp Immunol; 2011 Feb; 35(2):174-81. PubMed ID: 20869394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives.
    Yang JJ; Tao H; Li J
    Expert Opin Ther Targets; 2014 Sep; 18(9):1011-21. PubMed ID: 24935558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosis in the liver: acute protection and chronic disease.
    Lee Y; Friedman SL
    Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of SOCS-1 in the liver tissues of chronic hepatitis B and its clinical significance.
    Zhao ZX; Cai QX; Peng XM; Chong YT; Gao ZL
    World J Gastroenterol; 2008 Jan; 14(4):607-11. PubMed ID: 18203295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling and accelerated atherosclerosis in kidney disease.
    Wesoly J; Sikorski K; Lee CK; Bluyssen HA
    Acta Biochim Pol; 2010; 57(3):251-60. PubMed ID: 20725646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS proteins, cytokine signalling and immune regulation.
    Yoshimura A; Naka T; Kubo M
    Nat Rev Immunol; 2007 Jun; 7(6):454-65. PubMed ID: 17525754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and fibrogenesis.
    Friedman SL
    Semin Liver Dis; 1999; 19(2):129-40. PubMed ID: 10422196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of hepatic stellate cells, collagen types I and III synthesis and gene expression of selected cytokines during hepatic fibrogenesis following Mesocestoides vogae (Cestoda) infection in mice.
    Hrckova G; Velebný S; Solár P
    Int J Parasitol; 2010 Feb; 40(2):163-74. PubMed ID: 19631650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel anti-fibrotic modalities for liver fibrosis: molecular targeting and regenerative medicine in fibrosis therapy.
    Inagaki Y; Higashiyama R; Higashi K
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():85-8. PubMed ID: 22320923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and renin-angiotensin system signaling in hepatic fibrosis.
    Moreno M; Bataller R
    Clin Liver Dis; 2008 Nov; 12(4):825-52, ix. PubMed ID: 18984469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver.
    Baltayiannis G; Baltayiannis N; Tsianos EV
    J BUON; 2008; 13(2):263-5. PubMed ID: 18555475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor of cytokine signaling in allergic inflammation.
    Knisz J; Rothman PB
    J Allergy Clin Immunol; 2007 Mar; 119(3):739-45. PubMed ID: 17258308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.